RGCC Oncotrail
The complexity of cancer makes personalization vital to cancer treatment. RGCC Oncotrail is a groundbreaking diagnostic tool that is set to revolutionize cancer monitoring and management. The tests are tailored to address specific cancer types, including breast, prostate, colon, melanoma, lung, sarcoma, gastrointestinal, and more.
RGCC Oncotrace
RGCC Oncotrace serves as a valuable follow-up tool, accurately evaluating the therapeutic response of cancer treatment. It furnishes essential data necessary for comprehending and anticipating the prognosis of cancer.
RGCC Oncocount
RGCC Oncocount is a follow-up tool for cancer patients undergoing treatment, offering insight into the effectiveness of therapies and monitoring disease progression. Circulating Tumor Cells (CTCs) serve as potent biomarkers, their presence in the bloodstream signaling a potential resurgence of cancer.
